MacroGenics Appointments of Kuriakose and Vasconcelles to Board
MacroGenics announced the appointments of independent directors Emil Kuriakose and Michael Vasconcelles, effective October 30, 2026. These additions aim to strengthen the company's leadership and strategic direction for its oncology pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed